Shanghai Haohai Biological Technology Co., Ltd.
Symbol: 6826.HK
HKSE
42.45
HKDMarknadspris idag
15.1027
P/E-tal
0.7575
PEG-kvot
16.43B
MRK Aktiekapital
- 0.01%
DIV Avkastning
{{företagets_namn}} (6826-HK) Finansiella rapporter
Balansräkning
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 2751.1 | 2541.7 | 2907.2 | ||||||||||
balance-sheet.row.short-term-investments | 0 | 11.1 | 6.7 | 6.4 | ||||||||||
balance-sheet.row.net-receivables | 0 | 447.6 | 471.1 | 375.2 | ||||||||||
balance-sheet.row.inventory | 0 | 526.2 | 485.2 | 354.8 | ||||||||||
balance-sheet.row.other-current-assets | 0 | 25.2 | 34.1 | 69.6 | ||||||||||
balance-sheet.row.total-current-assets | 0 | 3750.1 | 3532.1 | 3712.6 | ||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 1553 | 1409.6 | 1248.9 | ||||||||||
balance-sheet.row.goodwill | 0 | 413 | 411.2 | 406.9 | ||||||||||
balance-sheet.row.intangible-assets | 0 | 729.1 | 783.5 | 783.1 | ||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 1142.1 | 1194.7 | 1190 | ||||||||||
balance-sheet.row.long-term-investments | 0 | 596 | 664.7 | 619 | ||||||||||
balance-sheet.row.tax-assets | 0 | 53.1 | 59.3 | 49.4 | ||||||||||
balance-sheet.row.other-non-current-assets | 0 | 11.1 | 32 | 130.5 | ||||||||||
balance-sheet.row.total-non-current-assets | 0 | 3355.4 | 3360.3 | 3237.8 | ||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-assets | 0 | 7105.5 | 6892.4 | 6950.4 | ||||||||||
balance-sheet.row.account-payables | 0 | 55.1 | 54.5 | 46.3 | ||||||||||
balance-sheet.row.short-term-debt | 0 | 216.6 | 34.4 | 66 | ||||||||||
balance-sheet.row.tax-payables | 0 | 58.4 | 52.1 | 17.8 | ||||||||||
balance-sheet.row.long-term-debt-total | 0 | 191.3 | 83.9 | 39.5 | ||||||||||
Deferred Revenue Non Current | 0 | 13.6 | 5.5 | 9.4 | ||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||
balance-sheet.row.other-current-liab | 0 | 444.2 | 422.4 | 375 | ||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 372.3 | 478.7 | 402.8 | ||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 54.2 | 61.3 | 46.7 | ||||||||||
balance-sheet.row.total-liab | 0 | 1088.2 | 990 | 890.1 | ||||||||||
balance-sheet.row.preferred-stock | 0 | 71.7 | 47 | 0 | ||||||||||
balance-sheet.row.common-stock | 0 | 171.5 | 174.1 | 175.8 | ||||||||||
balance-sheet.row.retained-earnings | 0 | 2728.6 | 2369.5 | 2309.7 | ||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -71.7 | -47 | 47.9 | ||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 2750 | 2971 | 3180 | ||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 5650.1 | 5514.6 | 5713.5 | ||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 7105.5 | 6892.4 | 6950.4 | ||||||||||
balance-sheet.row.minority-interest | 0 | 367.2 | 387.8 | 346.8 | ||||||||||
balance-sheet.row.total-equity | 0 | 6017.3 | 5902.4 | 6060.3 | ||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||
Total Investments | 0 | 607.1 | 671.4 | 625.3 | ||||||||||
balance-sheet.row.total-debt | 0 | 407.9 | 118.3 | 105.5 | ||||||||||
balance-sheet.row.net-debt | 0 | -2332.1 | -2423.5 | -2795.3 |
Kassaflödesanalys
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 508.3 | 235.7 | 382.6 | ||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 197.9 | 204.2 | 162.8 | ||||||||||
cash-flows.row.deferred-income-tax | 0 | -81.6 | 0 | 0 | ||||||||||
cash-flows.row.stock-based-compensation | 0 | 14.3 | 30.2 | 0 | ||||||||||
cash-flows.row.change-in-working-capital | 0 | 73.2 | -183.5 | 23.9 | ||||||||||
cash-flows.row.account-receivables | 0 | 0 | -52.3 | -41.9 | ||||||||||
cash-flows.row.inventory | 0 | -48.4 | -138.9 | -28.6 | ||||||||||
cash-flows.row.account-payables | 0 | 0 | 52.3 | 41.9 | ||||||||||
cash-flows.row.other-working-capital | 0 | 121.6 | -44.6 | 52.6 | ||||||||||
cash-flows.row.other-non-cash-items | 0 | -77.6 | -55.4 | -227.1 | ||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -267.2 | -317.1 | -272.1 | ||||||||||
cash-flows.row.acquisitions-net | 0 | 1.6 | 14.7 | -83.3 | ||||||||||
cash-flows.row.purchases-of-investments | 0 | -204.2 | -528.8 | -696.6 | ||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 14.6 | 9.1 | 749.3 | ||||||||||
cash-flows.row.other-investing-activites | 0 | 78.6 | 140.4 | 154.6 | ||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -376.6 | -681.8 | -148.1 | ||||||||||
cash-flows.row.debt-repayment | 0 | -16.4 | -47.9 | -95.5 | ||||||||||
cash-flows.row.common-stock-issued | 0 | 73.7 | 0 | -4 | ||||||||||
cash-flows.row.common-stock-repurchased | 0 | -270 | -147.7 | -44.9 | ||||||||||
cash-flows.row.dividends-paid | 0 | -68.5 | -121.9 | -87.9 | ||||||||||
cash-flows.row.other-financing-activites | 0 | -245.7 | 29.1 | 1.1 | ||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -257.7 | -288.4 | -231.3 | ||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 10 | 14.2 | -6.9 | ||||||||||
cash-flows.row.net-change-in-cash | 0 | 10.1 | -724.7 | -44 | ||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 569.3 | 559.2 | 1283.9 | ||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 559.2 | 1283.9 | 1327.9 | ||||||||||
cash-flows.row.operating-cash-flow | 0 | 634.5 | 231.3 | 342.3 | ||||||||||
cash-flows.row.capital-expenditure | 0 | -267.2 | -317.1 | -272.1 | ||||||||||
cash-flows.row.free-cash-flow | 0 | 367.2 | -85.9 | 70.2 |
Resultaträkning rad
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 2634.9 | 2103.4 | 1750.1 | ||||||||||
income-statement-row.row.cost-of-revenue | 0 | 781.4 | 656.5 | 490.4 | ||||||||||
income-statement-row.row.gross-profit | 0 | 1853.5 | 1446.9 | 1259.7 | ||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||
income-statement-row.row.other-expenses | 0 | -4 | -40.3 | -33.9 | ||||||||||
income-statement-row.row.operating-expenses | 0 | 1415.1 | 1226.8 | 1032.2 | ||||||||||
income-statement-row.row.cost-and-expenses | 0 | 2196.5 | 1883.3 | 1522.5 | ||||||||||
income-statement-row.row.interest-income | 0 | 77.7 | 87.9 | 98.2 | ||||||||||
income-statement-row.row.interest-expense | 0 | 7.3 | 7.6 | 5 | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -4.7 | -22.9 | -1.8 | ||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.other-operating-expenses | 0 | -4 | -40.3 | -33.9 | ||||||||||
income-statement-row.row.total-operating-expenses | 0 | -4.7 | -22.9 | -1.8 | ||||||||||
income-statement-row.row.interest-expense | 0 | 7.3 | 7.6 | 5 | ||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 197.9 | 204.2 | 162.8 | ||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.operating-income | 0 | 513 | 258.7 | 384.4 | ||||||||||
income-statement-row.row.income-before-tax | 0 | 508.3 | 235.7 | 382.6 | ||||||||||
income-statement-row.row.income-tax-expense | 0 | 96 | 45.4 | 35.4 | ||||||||||
income-statement-row.row.net-income | 0 | 416.1 | 180.5 | 352.2 |
Ofta ställda frågor
Vad är Shanghai Haohai Biological Technology Co., Ltd. (6826.HK) totala tillgångar?
Shanghai Haohai Biological Technology Co., Ltd. (6826.HK) totala tillgångar är 7105497000.000.
Vad är företagets årliga omsättning?
Den årliga intäkten är N/A.
Vad är företagets vinstmarginal?
Företagets vinstmarginal är 0.698.
Vad är företagets fria kassaflöde?
Fritt kassaflöde är 1.049.
Vad är företagets nettovinstmarginal?
Nettovinstmarginalen är 0.162.
Vad är företagets totala intäkter?
Totala intäkter är 0.177.
Vad är Shanghai Haohai Biological Technology Co., Ltd. (6826.HK) nettovinst (nettoinkomst)?
Nettovinst (nettoinkomst) är 416121000.000.
Vad är företagets totala skuldsättning?
Den totala skulden är 407949000.000.
Vad är rörelsens kostnader?
Rörelsens kostnader är 1415132000.000.
Vad är företagets kassaflöde?
Företagets kassa är 0.000.